| Detected | Trial | Change |
|---|---|---|
| 2026-06-10 | NCT07146230 The Selective Personalized Radio-Immunotherapy for Locally Advanced Non-Small Cell Lung… |
date change Primary completion pushed: 2027-12 -> 2028-04 |
| 2026-06-10 | NCT07146230 The Selective Personalized Radio-Immunotherapy for Locally Advanced Non-Small Cell Lung… |
date change Completion pushed: 2028-10 -> 2029-02 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT05221840 | A Global Study to Assess the Effects of Durvalumab With Oleclumab or Durvalumab With… | Non-Small Cell Lung Cancer | Active, Not Recruiting |
| NCT04590963 | Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus… | Squamous Cell Carcinoma of the Head and Neck | Active, Not Recruiting |
| Phase 2 | |||
| NCT06769126 | Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage… | Extensive Stage Lung Small Cell Carcinoma | Recruiting |
| NCT06503614 | A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer | Non-muscle Invasive Bladder Cancer | Recruiting |
| NCT05903092 | MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung… | Small Cell Lung Cancer | Recruiting |
| NCT05061550 | Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer | Non-small Cell Lung Cancer | Recruiting |
| NCT07146230 | The Selective Personalized Radio-Immunotherapy for Locally Advanced Non-Small Cell Lung… | Non-small Cell Lung Cancer | Not Yet Recruiting |